Statement from FDA Commissioner Scott Gottlieb, M.D. and Deputy Commissioner Anna Abram on new efforts to assure the quality of compounded drugs

FDA releases guidance with recommendations for protecting patients from the risk of contaminated or substandard compounded products produced by outsourcing facilities.

Original source: https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm628029.htm

Related Posts